Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4581116 | 0.86 | TSHR (0.52) | TSHRALDH1A1 | |
| SCHEMBL15520224 | 0.85 | ALDH1A1 (0.52) | TSHRALDH1A1 | |
| SCHEMBL5889388 | 0.82 | ALDH1A1 (0.57) | TSHRALDH1A1 | |
| SCHEMBL1902715 | 0.82 | ALDH1A1 (0.49) | TSHRALDH1A1 | |
| SCHEMBL35728 | 0.81 | ALDH1A1 (0.47) | TSHRALDH1A1MAPT | |
| SCHEMBL462000 | 0.81 | ALDH1A1 (0.56) | TSHRALDH1A1MAPT | |
| SCHEMBL8533766 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1 | |
| SCHEMBL15519572 | 0.81 | TSHR (0.47) | TSHRALDH1A1MAPT | |
| SCHEMBL11799300 | 0.81 | TSHR (0.55) | TSHRALDH1A1 | |
| SCHEMBL4888140 | 0.80 | ALDH1A1 (0.55) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| EP-4504844-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2025-02-12 | — | — | EP | claimed |
| US-20240240064-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2024-07-18 | — | — | US | claimed |
| EP-4334368-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2024-03-13 | — | — | EP | claimed |
| CN-117377706-A | Two-part curable composition | 博斯蒂克股份公司 | 2024-01-09 | — | — | CN | claimed |
| WO-2023194367-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2023-10-12 | — | — | WO | claimed |
| US-20230323137-A1 | COMPOSITION FOR SEALING COATED ELECTRIC WIRE, AND COATED ELECTRIC WIRE | TOAGOSEI CO. LTD. (JP) | 2023-10-12 | — | — | US | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| WO-2005006991-A2 | DEVICE AND METHOD FOR FALLOPIAN TUBE OCCLUSION | CHIROXIA LIMITED (IE) | 2005-01-27 | — | — | WO | claimed |
| US-20040013614-A1 | Acrylic-based adhesive composition | BTG INTERNATIONAL LIMITED (GB) | 2004-01-22 | — | — | US | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| EP-1341563-A1 | ACRYLIC-BASED ADHESIVE COMPOSITION | UNIVERSIDAD DE ALICANTE (ES) | 2003-09-10 | — | — | EP | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| WO-2002009784-A1 | ACRYLIC-BASED ADHESIVE COMPOSITION | UNIVERSIDAD DE ALICANTE (ES) | 2002-02-07 | — | — | WO | claimed |
| US-5922783-A | METALLOCENE, PHOTOINITIATOR, CYANOACRYLATE COMPONENT; REDUCED BLOOMING, CRAZING | LOCTITE CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
| US-5530037-A | COMBINATION OF AN ANIONIC STABILIZER AND A FREE-RADICAL STABILIZER; STORAGE STABILITY | LOCTITE (IRELAND) LIMITED (IE) | 1996-06-25 | — | — | US | claimed |
| US-5135784-A | Wrapping web container and cutter for cutting wrapping web | AYAKO OKUMURA (JP) | 1992-08-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013614-A1 | Acrylic-based adhesive composition | C5AR1, C1R, COL2A1 | TSHR 459/4885ALDH1A1 980/4885TP53 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.